Business Context and Reporting Period
This Form 8-K Current Report was filed by Lifemd, Inc. on February 9, 2023, covering events occurring on February 4, 2023. The filing details an amendment to a previously disclosed Stock Purchase Agreement with Cleared Technologies, PBC ("Cleared"), originally entered into on January 11, 2022.
Key Financial Metrics and Transaction Details
The filing focuses on the restructuring of the acquisition payment terms rather than standard operating financial metrics. Key transaction figures include:
- Revised Total Purchase Price: $3,670,000 (reduced by $250,000 from the original agreement).
- Payment Structure:
- $460,000 paid at closing (already completed).
- Remaining balance to be paid in 5 quarterly installments.
- Installment period: February 6, 2023, through January 15, 2024.
- Equity Consideration: The Company may issue common stock in lieu of cash to accredited investors under Section 4(a)(2) and Rule 506 exemptions.
Note: This filing does not provide data on revenue, profit, cash flow, margins, debt, or liquidity for the reporting period.
Material Changes Versus Prior Period
Compared to the original January 2022 agreement, the following material changes were implemented:
- Price Reduction: Total consideration decreased by $250,000.
- Elimination of Earn-outs: All "earn-out" payments previously payable to sellers were removed.
- Payment Timing: The schedule was adjusted to a specific 5-quarter installment plan ending in January 2024.
- Contractual Terms: Certain representations and warranties from both the Company and Sellers were removed.
Guidance, Outlook, and Risks
The filing contains standard cautionary statements regarding forward-looking information. Management notes that statements regarding the acquisition's plans, expectations, and benefits are subject to risks and uncertainties. The Company explicitly states it does not assume an obligation to update forward-looking statements except as required by law. No specific financial guidance or outlook for future periods is provided in this document.
Key Facts for Investor Verification
- Verify the impact of the $250,000 purchase price reduction on the Company's cash flow projections.
- Confirm the specific dates and amounts of the five quarterly installments due between February 2023 and January 2024.
- Review the implications of removing "earn-out" provisions on the potential upside value of the Cleared Technologies acquisition.
- Check subsequent filings to determine if the Company elected to pay the remaining balance in cash or via the issuance of common stock to accredited investors.